Summary
Introduction
Low serum HDL concentrations have been shown to be a risk factor for coronary heart disease (Gordon, Castelli, Hjortland, Kannel & Dawber, 1977a) . Serum concentrations of HDL are lowered in people with glucose-intolerance (Gordon 1977a; Cornwell, Kruger, Hamwi & Brown, 1961) . This may be an important risk factor for coronary heart disease, especially in female diabetics (Gordon, Castelli, Hjortland, Kannel & Dawber, 1977b; Reckless, Betteridge, Wu, Payne & Galton, 1978) .
It has been demonstrated that the concentrations of glycosylated haemoglobins HbA,,, HbA,, and HbA,, are elevated in the erythrocytes of diabetics (Gabbay, Hasty, Breslow, Ellison, Bunn & Gallop, 1977; Trivelli, Ranney & Lai, 1971 ). These concentrations can be decreased by lowering the overall blood-glucose concentrations, but the reduction in concentration of glycosylated haemoglobins occurs only after a lag of 3 to 4 weeks (Koenig, Peterson, Jones, Saudek, Lehrman & Cerami, 1976) . This observation suggests that estimation of the concentration of glycosylated haemoglobins in the blood of a diabetic will give a value that is related to the blood-glucose concentrations over several weeks.
In order to determine whether concentrations of HDL are affected by the quality of blood-glucose control, we have studied the relationship between levels of glycosylated haemoglobins and those of HDL cholesterol in diabetic patients.
Methods
Spot blood samples were collected between 1 and 4 h after lunch from 171 patients (158 European and 13 Asian) attending a diabetic clinic. It has previously been demonstrated that concentrations of HDL cholesterol are not affected by the prior ingestion of food (Havel, 1957) . Part of each sample (2.5 ml) was put in a standard fluoride oxalate bottle and refrigerated at 4OC and the remainder was separated and the serum frozen. Estimation of blood-glucose concentrations was performed by a Technicon AA I1 automated Trinder's (1969) method. The combined concentrations of HbA,,, HbAlb and HbA,,, hereafter expressed as HbAl(,+b+c), were estimated on 50 pl of the fluoride blood within seven days of collection by a micro-scale ion-exchange column method (Welch & Boucher, 1978) . The coefficient of variation of this assay was 1.8% within-assay and 3.6% between-assay. The concentration of HDL cholesterol in the serum was estimated within 2 weeks of collection by the method of Burstein & Samaille (1960) , in which other lipoproteins are precipitated by heparin and manganese chloride; the concentration of cholesterol in the supernatant was then measured by using Technicon method N24a. The coefficient of variation of the HDLcholesterol assay was 2.6% within-assay and 4.3% between-assay .
Values are expressed as means & SEM. Statistical comparisons were made by simple linear regression, and by unpaired t-test. Where the data were non-parametric in distribution, Spearman rank correlation and the Mann-Whitney U-test were employed; these analyses are denoted by *.
Results
The mean concentrations of HDL cholesterol were higher in female patients and in those taking insulin (Table 1) . There was no significant relationship in either sex between the concentrations of HDL cholesterol and the type of oral hypoglycaemic therapy, or the frequency of insulin administration. The mean HDL cholesterol concentrations in a small number of Asian patients was significantly lower than those in Europeans. The HDL-cholesterol concentration was not significantly affected by age (P > 0.3*).
The mean concentration of HbA1(a+b+c) in 164 diabetic patients was 11.61 f 2.44%, which was significantly higher (P < 0.001) than that in 45 non-diabetic people (8.48 f 1.20%). There was no sex difference in HbAl(,+b+c) concentrations (Table 2 ), but the mean value was significantly higher in patients on insulin than in insulin-independent patients, and in European patients as compared with Asian patients. There was no relationship between the concentration of HbAl(,+btc) and the type of oral hypoglycaemic therapy or the frequency of insulin administration. A correlation was found between amounts of HbAl(,+b+c) and random blood-glucose concentrations (r = 0.52, P < 0.0001*, n = 164), but there was no effect of age on the concentrations of HbAl(,+b+e) (P > 0.2). There was no significant correlation between the concentrations of HbAl(,+b+c) and of HDL cholesterol in the patients taken as a whole (Table  3) . Of the patient subgroups, a weak positive correlation was found between concentrations of HbAl(,+b+c) and of HDL cholesterol in insulinindependent patients and in males. In the group of 43 male patients not requiring insulin, this correlation was more significant (P < 0.005*), but no correlation was found in male patients on insulin or in female patients not requiring insulin.
In 13 patients, a second sample of blood was taken for re-estimation of HDL cholesterol and HbAl(,+b+c) after an interval of between 2 and 4 weeks. There was no correlation between the 
Discussion
Previous studies have demonstrated that in diabetic subjects, the concentration of glycosylated haemoglobins correlates positively both with serum cholesterol (Gabbay et al., 1977; Peterson, Koenig, Jones, Saudek & Cerami, 1977) and with serum triglyceride concentrations (Peterson er al., 1977) . Such observations suggest that the hyperlipidaemias of diabetic patients may be correctable by improving blood-glucose control.
Patients with glucose intolerance have low concentrations of HDL cholesterol in their serum (Gordon et al., 1977a) , and in patients who are commenced on treatment with insulin, the HDLcholesterol concentration rises (Cornwell er al.,  1961) . For this reason, it was expected that an inverse correlation might be found between the concentrations of HbAl(,+b+c) and of HDL cholesterol. Such a relationship was not found in the patients as a whole, or in any subgroup of patients. In fact we have demonstrated a significant positive correlation between HbAl(,+b+c) and HDL-cholesterol concentrations in male diabetic subjects not requiring insulin. We have, furthermore, found no significant effect of alterations in blood-glucose control, as indicated by changing concentrations of HbAl(,+b+c), on HDL-cholesterol concentrations.
